Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
BEFREE |
Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population.
|
31401635 |
2019 |
Primary hyperoxaluria type III
|
0.780 |
Biomarker
|
disease |
BEFREE |
We also propose that loss of HOGA1 function could increase oxalate production in PH3 by decreasing pyruvate availability and metabolic flux through the Krebs cycle.
|
31696211 |
2019 |
Primary hyperoxaluria type III
|
0.780 |
Biomarker
|
disease |
BEFREE |
Genetic analysis (targeted gene panel-based and/or whole-exome sequencing) of HOGA1 was performed in 52 patients with a high suspicion of PH3, and DNA was obtained from the patient and both the parents.
|
31123811 |
2019 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to report three PH3 cases carrying mutations in HOGA1.
|
27561601 |
2017 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III.
|
28711958 |
2017 |
Primary hyperoxaluria type III
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Cellular degradation of 4-hydroxy-2-oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3.
|
27096395 |
2016 |
Primary hyperoxaluria type III
|
0.780 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Primary hyperoxaluria type III
|
0.780 |
Biomarker
|
disease |
BEFREE |
Primary hyperoxaluria type-3 is characterized by increased oxalate production caused by mutations in the HOGA1 gene encoding 4-hydroxy-2-oxoglutarate aldolase (HOGA1).
|
27096395 |
2016 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
Performance evaluation of Sanger sequencing for the diagnosis of primary hyperoxaluria and comparison with targeted next generation sequencing.
|
25629080 |
2015 |
Primary hyperoxaluria type III
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.
|
25644115 |
2015 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
4-hydroxyglutamate is a biomarker for primary hyperoxaluria type 3.
|
24563386 |
2015 |
Primary hyperoxaluria type III
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Performance evaluation of Sanger sequencing for the diagnosis of primary hyperoxaluria and comparison with targeted next generation sequencing.
|
25629080 |
2015 |
Primary hyperoxaluria type III
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
4-hydroxyglutamate is a biomarker for primary hyperoxaluria type 3.
|
24563386 |
2015 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
Renal function can be impaired in children with primary hyperoxaluria type 3.
|
25972204 |
2015 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
BEFREE |
Primary hyperoxaluria type 3 (PH3) is characterized by mutations in the 4-hydroxy-2-oxoglutarate aldolase (HOGA1) gene.
|
25972204 |
2015 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
BEFREE |
Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3.
|
26340091 |
2015 |
Primary hyperoxaluria type III
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.
|
22781098 |
2013 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.
|
22771891 |
2012 |
Primary hyperoxaluria type III
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type III.
|
22851625 |
2012 |
Primary hyperoxaluria type III
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.
|
22771891 |
2012 |
Primary hyperoxaluria type III
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.
|
22391140 |
2012 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.
|
22391140 |
2012 |
Primary hyperoxaluria type III
|
0.780 |
CausalMutation
|
disease |
CLINVAR |
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
|
21896830 |
2011 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
|
21896830 |
2011 |
Primary hyperoxaluria type III
|
0.780 |
GeneticVariation
|
disease |
CLINVAR |
Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria.
|
21998747 |
2011 |